Lisinopril and Hydrochlorothiazide

Product NDC
60760-860
11-digit product format
607600860
Labeler code
60760
Product ID
60760-860_8a1eae05-bcbc-180c-e053-2995a90a349e
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Lisinopril and Hydrochlorothiazide
Dosage form
TABLET
Route
ORAL
Labeler
St. Mary's Medical Park Pharmacy
Application
ANDA076194
Marketing category
ANDA
Marketing start
2019-05-29
Marketing end
0000-00-00
Substance
LISINOPRIL; HYDROCHLOROTHIAZIDE
Active strength
10 mg/1; mg/1
Pharmacologic classes
Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
NDC exclude flag
No
Listing certified through
2020-12-31
Current FDA listing
Historical FDA.report record

Related Records

Related UNII Ingredients

UNIIPreferred termRegistry numberMatched term
E7199S1YWRLISINOPRIL83915-83-7LISINOPRIL
0J48LPH2THHYDROCHLOROTHIAZIDE58-93-5HYDROCHLOROTHIAZIDE

Packages

Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
60760-860-906076008609090 TABLET in 1 BOTTLE, PLASTIC (60760-860-90) 90 tablet2019-05-290000-00-00NoNoCurrent